CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (unaudited) - USD ($)	Total	Additional Paid-In Capital	Accumulated Deficit	Accumulated other comprehensive loss	Common Stock Class A [Member]	Common Stock Class B [Member]
Balance, shares at Dec. 31, 2019					115,245,000
Balance, amount at Dec. 31, 2019	$ 488,733	$ 608,616	$ (231,193)	$ (3,935)	$ 115,245	$ 0
Capital contributions to Yubo Beijing	504,892	504,892
Net loss for the three months ended March 31, 2020	(140,948)	0	(140,948)	0	0	0
Foreign currency translation adjustment	(24,516)	0	0	(24,516)	$ 0	0
Balance, shares at Mar. 31, 2020					115,245,000
Balance, amount at Mar. 31, 2020	828,161	1,113,508	(372,141)	(28,451)	$ 115,245	0
Balance, shares at Dec. 31, 2019					115,245,000
Balance, amount at Dec. 31, 2019	488,733	608,616	(231,193)	(3,935)	$ 115,245	0
Net loss for the three months ended March 31, 2020	(172,894)
Balance, shares at Jun. 30, 2020					115,245,000
Balance, amount at Jun. 30, 2020	786,199	1,113,508	(404,087)	(38,467)	$ 115,245	0
Balance, shares at Mar. 31, 2020					115,245,000
Balance, amount at Mar. 31, 2020	828,161	1,113,508	(372,141)	(28,451)	$ 115,245	0
Net loss for the three months ended March 31, 2020	(31,946)	0	(31,946)	0	0	0
Foreign currency translation adjustment	(10,016)	0	0	(10,016)	$ 0	0
Balance, shares at Jun. 30, 2020					115,245,000
Balance, amount at Jun. 30, 2020	786,199	1,113,508	(404,087)	(38,467)	$ 115,245	0
Balance, shares at Dec. 31, 2020					117,000,000
Balance, amount at Dec. 31, 2020	1,167,619	1,991,617	(942,994)	1,996	$ 117,000	0
Capital contributions to Yubo Beijing	127,164	127,164	0	0	0	0
Net loss for the three months ended March 31, 2020	(438,676)	0	(438,676)	0	0	0
Foreign currency translation adjustment	70,413	0	0	70,413	$ 0	$ 0
Reverse acquisitions of Yubo International Biotech Limited by Plantium International Biotech Co. Ltd., shares					1,177,885	4,447
Reverse acquisitions of Yubo International Biotech Limited by Plantium International Biotech Co. Ltd., amount	(0)	(1,182)	0	0	$ 1,178	$ 4
Balance, shares at Mar. 31, 2021					118,177,885	4,447
Balance, amount at Mar. 31, 2021	926,520	2,117,599	(1,381,670)	72,409	$ 118,178	$ 4
Balance, shares at Dec. 31, 2020					117,000,000
Balance, amount at Dec. 31, 2020	1,167,619	1,991,617	(942,994)	1,996	$ 117,000	$ 0
Net loss for the three months ended March 31, 2020	(808,683)
Balance, shares at Jun. 30, 2021					118,177,885	4,447
Balance, amount at Jun. 30, 2021	569,634	2,117,599	(1,751,678)	85,531	$ 118,178	$ 4
Balance, shares at Mar. 31, 2021					118,177,885	4,447
Balance, amount at Mar. 31, 2021	926,520	2,117,599	(1,381,670)	72,409	$ 118,178	$ 4
Net loss for the three months ended March 31, 2020	(370,008)	0	(370,008)	0	0	0
Foreign currency translation adjustment	13,122	0	0	13,122	$ 0	$ 0
Balance, shares at Jun. 30, 2021					118,177,885	4,447
Balance, amount at Jun. 30, 2021	$ 569,634	$ 2,117,599	$ (1,751,678)	$ 85,531	$ 118,178	$ 4